Skip to content

endoscopic full-thickness resection for gastrointestinal submucosal tumors

A prospective study of endoscopic full-thickness resection for gastrointestinal submucosal tumors in single-center - EFTR for gastric SMT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052588
Enrollment
13
Registered
2023-10-25
Start date
2023-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric submucosal tumor

Interventions

The study will be divided into three phases with a total of 13 patients. In all cases, EFTR will be performed by physicians who meet certain criteria and are skilled in endoscopic procedures. Phase 1

Sponsors

National Cancer Center Hospital Endoscopy Division Yutaka Saito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligibility Criteria 1) Preoperative diagnosis of gastric submucosal tumor between 2 cm and 3 cm by CT and ultrasound endoscopy (EUS) 2) A gastric submucosal tumor of 2 cm or less that meets one of the following conditions a) GIST (gastrointestinal stromal tumor) diagnosed or suspected by imaging or histological diagnosis b) Suspected malignant findings such as ulceration, irregular margins, or tendency to enlarge. 2) Patients who can be resected by laparoscopic local excision (including LECS) at the institution 3) The line of resection does not extend to the spleen or pylorus, and there is no problem with endoscopic movement during preoperative endoscopy, and EFTR is judged to be feasible *1 4) It is judged that there is sufficient space for full-layer suture after EFTR. 5) Gastric submucosal tumor is of intraductal or intramural type. 6) No previous epigastric surgery and no previous surgery involving resection of the intestinal tract (including the stomach). However, patients with no postoperative ileus despite a history of the following examinations and surgeries are acceptable. (1) Laparoscopy or laparoscopic and laparoscopic (assisted) appendicectomy for appendicitis Laparoscopic cholecystectomy for cholelithiasis Laparoscopic and laparoscopic (assisted) resection of the sigmoid colon 4) Open and laparoscopic (assisted) resection of the rectum (without stoma) 7) Age at enrollment: 18 years or older 8) Performance status (PS) of 0-1 according to ECOG criteria 9) Patient's written consent to participate in the study 1 The three cases in the first stage are defined as lesions with tumor margins more than 3 cm away from the eruption/pylorus.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Gastric submucosal tumor of extrapubic origin 2) Temporary withdrawal of antiplatelet agents or anticoagulants is not possible 3) Platelet count less than 50,000/mm3 or PT-INR greater than 2 in patients not taking anticoagulants 4) Patients with liver cirrhosis that falls into the B-C category on the Child-Pugh score 5) Patients with chronic renal failure on maintenance dialysis 6) Patients whose EFTR resection line is considered to extend to the spleen or pylorus. 7) Patients whose attending physician determines that participation in this study is inappropriate. Discontinuation Criteria 1) When it is considered necessary to proceed to laparotomy. 2) If the attending physician or surgeon determines that EFTR is not feasible prior to the start of ETFR

Design outcomes

Primary

MeasureTime frame
Completion rate of EFTR and endoscopic suturing

Secondary

MeasureTime frame
en-bloc, complete resection rate for EFTR the time required for EFTR and suturing Intraoperative and postoperative adverse event rate

Countries

Japan

Contacts

Public ContactMai Makiguchi

National Cancer Center Hospital Endoscopy division

mego@ncc.go.jp0335422511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026